DC-cik treatment

Clinical trials for DC-cik treatment explained in plain language.

Never miss a new study

Get alerted when new DC-cik treatment trials appear

Sign up with your email to follow new studies for DC-cik treatment, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New immune combo tackles Hard-to-Treat colorectal cancer

Disease control Recruiting now

This early-phase trial tests a combination of three treatments for advanced colorectal cancer that has not responded to standard therapies. The approach uses the patient's own immune cells (DC-CIK), a targeted drug (regorafenib), and a bispecific antibody to boost the immune syst…

Matched conditions: DC-CIK TREATMENT

Early phase 1 • Sponsor: JIANG LONGWEI • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC

DC-cik treatment

Get alerted when new DC-cik treatment trials appear

New immune combo tackles Hard-to-Treat colorectal cancer